AIM-HI Accelerator Fund announces winners of the 2025 Venture Competition
Grant and Award Announcement
Updates every hour. Last Updated: 10-Oct-2025 19:11 ET (10-Oct-2025 23:11 GMT/UTC)
In its mission to accelerate transformative cancer innovations and drive cures forward, the AIM-HI Accelerator Fund is pleased to announce the winners of the 2025 AIM-HI Venture Competition: ResNovas Therapeutics, co-founded by Nobel Laureate Carolyn Bertozzi, Ph.D., Michelle Arkin, Ph.D., CTO Ian Churcher, Ph.D., and CEO Gabriele Sulli, Ph.D.; and Chiara Biosciences, co-founded by National Academy of Inventors Fellow Francis Barany, Ph.D. and CEO Kirsten Flowers, MBA.
A smoking cessation program developed by WashU Medicine researchers and deployed at Siteman Cancer Center prolongs life for cancer patients, according to a new study. Regardless of their type of cancer or how advanced it was, cancer patients lived nearly a year longer when they quit smoking compared to patients who continued smoking.
Australia needs to be innovative when it comes to skin cancer detection by embracing a nurse-led model that could save thousands of lives in the long run, according to a new paper.
By integrating key advances from multiple laboratories and disciplines, researchers provide a framework for understanding how nanomedicine can transform cancer immunotherapy, a step toward next-generation patient treatments.